Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R First

Showing results (261-270 of 266) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 266 results.
Transplantation Proceedings|April 26, 2005
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionR E Boardman, R R Alloway, J W Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2017
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and PlatformS M Kurian, E Velazquez, R Thompson, et al.
Transplantation|November 7, 1999
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research GroupJ W Alexander, J A Light, L A Donaldson, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
Transplantation Proceedings|April 14, 2019
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal FunctionC L Marsh, S M Kurian, J C Rice, et al.
Transplantation|July 29, 1998
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantationA O Gaber, M R First, R J Tesi, et al.
Pageof 27

Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
Transplantation Proceedings|April 26, 2005
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionR E Boardman, R R Alloway, J W Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 12, 2017
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and PlatformS M Kurian, E Velazquez, R Thompson, et al.
Transplantation|November 7, 1999
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research GroupJ W Alexander, J A Light, L A Donaldson, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
Transplantation Proceedings|April 14, 2019
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal FunctionC L Marsh, S M Kurian, J C Rice, et al.
Transplantation|July 29, 1998
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantationA O Gaber, M R First, R J Tesi, et al.
Pageof 27